T

THC Farmaceuticals Inc
OTC:CBDG

Watchlist Manager
THC Farmaceuticals Inc
OTC:CBDG
Watchlist
Price: 0.0457 USD Market Closed
Market Cap: $828.5k

Net Margin

-796.1%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-796.1%
=
Net Income
$-60.5k
/
Revenue
$7.6k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-796.1%
=
Net Income
$-60.5k
/
Revenue
$7.6k

Peer Comparison

Country Company Market Cap Net
Margin
US
THC Farmaceuticals Inc
OTC:CBDG
760.1k USD
Loading...
US
Cintas Corp
NASDAQ:CTAS
75.5B USD
Loading...
US
Copart Inc
NASDAQ:CPRT
38.6B USD
Loading...
US
RB Global Inc
F:J1F
18.1B EUR
Loading...
CA
Ritchie Bros Auctioneers Inc
TSX:RBA
28.8B CAD
Loading...
AU
Brambles Ltd
ASX:BXB
30.9B AUD
Loading...
FR
Spie SA
PAR:SPIE
7.8B EUR
Loading...
US
Aurora Innovation Inc
NASDAQ:AUR
8.5B USD
Loading...
FR
Elis SA
PAR:ELIS
5.7B EUR
Loading...
DK
Iss A/S
CSE:ISS
40.5B DKK
Loading...
US
IAA Inc
F:3NI
4.9B EUR
Loading...

Market Distribution

Lower than 92% of companies in the United States of America
Percentile
8th
Based on 15 072 companies
8th percentile
-796.1%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

THC Farmaceuticals Inc
Glance View

THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The company manufactures and markets cannabis extract products made from cannabis. The firm's facility is located in Southern California. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.

CBDG Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-796.1%
=
Net Income
$-60.5k
/
Revenue
$7.6k
How has Net Margin changed over time?

Over the last 2 years, THC Farmaceuticals Inc’s Net Margin has decreased from -437.1% to -796.1%. During this period, it reached a low of -796.1% on Oct 30, 2020 and a high of 418.2% on Dec 31, 2019.

Back to Top